The benefits of semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, aren’t just limited to treating obesity. New research shows that semaglutide can protect people’s hearts regardless of how many pounds they lose while taking it. Scientists examined data from a large-scale clinical trial of people with obesity and pre-existing cardiovascular disease. Compared […]
A Staggering Number of Americans Are Now Considered Obese Under New Definition
If you’ve ever wondered, even briefly, whether you have obesity, you might want to double-check right about now. New research suggests that over two-thirds of Americans are considered obese under criteria released this year—well above the obesity rate based on the older standard. Researchers at Mass General Brigham examined health records from a large, diverse […]
Ozempic Is an ‘Essential’ Drug, WHO Says as Agency Calls for Cheaper Generics
One of the world’s most sought-after drugs has officially become a vital medication. The World Health Organization has just added semaglutide—the active ingredient in Ozempic and Wegovy—to its list of essential medicines. The WHO’s Model Lists of Essential Medicines is designed to improve affordability and access for the world’s most impactful drugs. Semaglutide and other […]
A Pill to Fight Obesity Is on the Verge of Approval
The next big obesity medication coming down the pipeline will likely come in pill form. Eli Lilly has just released the latest positive Phase III trial results of its experimental oral GLP-1 drug, orforglipron. On Tuesday morning, Eli Lilly reported that orforglipron met the benchmarks of the company’s Phase III ATTAIN-2 study. People taking orforglipron […]